Navigation Links
Tranziger Announces Formation of Global Advisory & Development Team
Date:10/7/2009

LONDON and WASHINGTON, Oct. 7 /PRNewswire/ -- Tranziger Limited announced today the formation of its global advisory and business team to advise and assess companies in the life sciences and healthcare sectors to execute strategic transactions and realise and optimise value from their portfolios in these turbulent times. Tranziger Limited is headquartered in London, England, UK and has offices in Washington, DC and Edinburgh.

The Tranziger team will be attending the upcoming BioPartnering Europe conference from October 12-14 at the Queen Elizabeth Conference Centre in London.

Established in early 2009 by a group of senior, highly experienced international corporate business transactional professionals, Tranziger aims to help the managers and owners of small and mid-tier companies in the Biotechnology, Pharmaceutical, Diagnostics and Medical Technology sectors realise value in the currently challenging global economic environment. The group offers strategic transaction advisory and execution services including Mergers and Acquisitions, Corporate and Commercial Development, Corporate Partnering, technical due diligence, and strategic R&D consultancy. Tranziger also has a proprietary service for venture formation, development and commercialisation utilised by larger corporations, universities, government agencies and investment organizations.

Tranziger distinguishes itself from other groups by the fact that its team members originate from the same peer group as many of their prospective clients and deal partners, combining scientific acumen with seasoned experience at the transactional coalface. The group's geographical reach extends to Europe, North America and Asia Pacific, offering scope for a wider base of creative solutions and deal potential.

Dr. V. Paul Gerskowitch, Executive Chairman of Tranziger, said, "The global downturn has caused an intense reevaluation of business models and priorities. Very many newer spinout and mid-tier companies will struggle to survive, doomed by an inability to raise sufficient capital, partner or grow organically. At the same time, larger companies are increasingly staking claims earlier in all phases of technology development."

Neil J. Campbell, Managing Director, North America, said, "As investors focus ever more on those companies with quality data and revenue potential, the life science and healthcare sectors will likely selectively consolidate around those with top quality offerings. Increasingly, there will be a shift away from financial engineers to business builders. This will be brought about by the rise of so-called third age entrepreneurs and the need to derive more value from technology portfolios, thus spreading the risk. Proactive portfolio management and product/technology life cycle management, achieved via Tranziger's Portfolio Partnering model, will become an ever more urgent and value-driving activity for companies."

About Tranziger Limited

Tranziger was established in 2009 by a group of senior, highly experienced international corporate business transactional professionals. Tranziger aims to help the managers and owners of small and mid-sized companies in the Biotechnology, Pharmaceutical, Diagnostics and Medical Technology sectors realise value in the currently challenging global economic environment. The group offers strategic transaction advisory and execution services including Mergers and Acquisitions, Corporate and Commercial Development, Corporate Partnering, technical due diligence, and strategic R&D consultancy. Tranziger also has a proprietary service for venture formation, development and commercialization utilised by larger corporations, universities, government agencies and investment organizations. Further information about Tranziger can be found at www.tranziger.com.

    Contact:
    Tranziger, Limited
    +44 20 8663 3472
    Dr. Paul Gerskowitch, Executive Chairman
    gerskowitch@tranziger.com
    or
    Neil Campbell, Managing Director North American Operations
    +1 301 792 4345
    campbell@tranziger.com

    Tiberend Strategic Advisors, Inc.
    212-827-0020

    Andrew Mielach
    amielach@tiberendstrategicadvisors.com
    or
    Farrell Denby
    fdenby@tiberendstrategicadvisors.com

SOURCE Tranziger Limited


'/>"/>
SOURCE Tranziger Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Telesoft Announces Advanced Dispute Management Capabilities with Version 9.5
2. Cardiovascular Systems Announces Plans for Second Manufacturing Facility - New Facility Expands CSI's Capacity to Produce Peripheral Arterial Disease Systems
3. Health Department Announces First Doses of H1N1 Vaccine Arrive in Pennsylvania
4. Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports
5. NIH announces expansion of Rare Diseases Clinical Research Network
6. bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID(R) Molecular Cancer Classifier in United Kingdom, Ireland and Middle East Countries
7. One Source Industries Announces Promotion
8. The Symphony Guild Announces Artist Lineup for 2009 Event
9. Hanger Orthopedic Group, Inc. Announces Third Quarter 2009 Earnings Release Conference Call
10. China-Biotics, Inc. Announces Closing of Public Offering of Common Stock
11. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... ... ... and Overseer at The House of Yahweh in Abilene, Texas, has published a new post ... Yisrayl says with so many titles and names for the Creator, it’s hard for ... little Scripture, backed with a lot of research, the truth is undeniable. , “If ...
(Date:4/28/2017)... New York, New York (PRWEB) , ... April ... ... of high-quality anti-aging skincare and advanced nutraceutical supplements, through its Nova ... fast-absorbing cream provides the hydrating benefits of a moisturizer with the power of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Deutsche Bank Securities 42nd ... Boston, Massachusetts on Wednesday, May ... Eastern Time. A live webcast of the ... website at http://investor.zimmerbiomet.com .  The webcast will be ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
Breaking Medicine Technology: